Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast Cancer
New England Journal of Medicine · 07.08.2025 · 393 (6) · 556-568
DOI: 10.1056/nejmoa2505725 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 07.08.2025. Verfasst von Mario Campone und 27 weiteren Autor:innen. Beteiligte Einrichtung: Institut de Cancérologie de l'Ouest Angers-Nantes, Saint-Herblain, France. Hauptthemen laut MEDLINE: Antineoplastic Agents, Hormonal, Breast Neoplasms, Estrogen Receptor alpha, Proteolysis Targeting Chimera. Die Arbeit wurde bisher 191-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Arvinas Estrogen Receptor, Inc., Pfizer, Inc..
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institut de Cancérologie de l'Ouest Angers-Nantes, Saint-Herblain, France.
- Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale," Naples, Italy.
- Memorial Sloan Kettering Cancer Center, New York.
- Weill Cornell Medical College, New York.
- Shanghai Cancer Center, Fudan University, Shanghai, China.
- Centre Georges Francois Leclerc, Dijon, France.
ORCID-Profile: Ahmet Sezer
Förderung
- Arvinas Estrogen Receptor, Inc.
- Pfizer, Inc.
Zitieren
APA
Campone, M., De Laurentiis, M., Jhaveri, K., Hu, X., Ladoire, S., Patsouris, A., Zamagni, C., Cui, J., Cazzaniga, M., Cil, T., Jerzak, K. J., Fuentes, C., Yoshinami, T., Rodriguez-Lescure, A., Sezer, A., Fontana, A., Guarneri, V., Molckovsky, A., Mouret-Reynier, M. A., …, & VERITAC-2 Study Group (2025). Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast Cancer. New England Journal of Medicine, 393(6), 556-568. https://doi.org/10.1056/nejmoa2505725
Vancouver
Campone M, De Laurentiis M, Jhaveri K, Hu X, Ladoire S, Patsouris A, et al. Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast Cancer. New England Journal of Medicine. 2025;393(6):556-568. doi:10.1056/nejmoa2505725
BibTeX
@article{Campone2025,
author = {Campone, Mario and De Laurentiis, Michelino and Jhaveri, Komal and Hu, Xichun and Ladoire, Sylvain and Patsouris, Anne and Zamagni, Claudio and Cui, Jiuwei and Cazzaniga, Marina and Cil, Timucin and Jerzak, Katarzyna J and Fuentes, Christian and Yoshinami, Tetsuhiro and Rodriguez-Lescure, Alvaro and Sezer, Ahmet and Fontana, Andrea and Guarneri, Valentina and Molckovsky, Andrea and Mouret-Reynier, Marie-Ange and Demirci, Umut and Zhang, Yongqiang and Valota, Olga and Lu, Dongrui R and Martignoni, Marcella and Parameswaran, Janaki and Zhi, Xin and Hamilton, Erika P and VERITAC-2 Study Group, VERITAC-2 Study Group},
title = {Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast Cancer},
journal = {New England Journal of Medicine},
year = {2025},
volume = {393},
number = {6},
pages = {556--568},
doi = {10.1056/nejmoa2505725}
}
EUVIMED